Financial News
All News about Amphastar Pharma
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_23320.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/07/watch2.jpg)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Amphastar Receives FDA Approval for Vasopressin
July 19, 2022
Via ACCESSWIRE
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/26702.png?v=0)
Amphastar Receives FDA Approval for Vasopressin
July 19, 2022
Via AccessWire
Exposures
Product Safety
![](https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg)
![](https://www.investors.com/wp-content/uploads/2018/12/stock-medical-trials-01-adobe.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU77.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU33.jpg)
![](https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU6.jpg)
![](https://www.investors.com/wp-content/uploads/2019/09/stock-drug-research-01-adobe.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU33.jpg)
![](https://www.investors.com/wp-content/uploads/2017/03/IDS4.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU2.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU33.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU6.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU4.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_10173.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/06/10/yesterdays_movers.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/06/09/mid-day_movers_image.jpg?width=1200&height=800&fit=crop)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/26702.png?v=0)
Via AccessWire
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_1630.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU6.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/26702.png?v=0)
Amphastar Receives FDA Approval for Regadenoson
May 24, 2022
Via AccessWire
Exposures
Product Safety
![](https://investorplace.com/wp-content/uploads/2019/07/small-cap-winner.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU5.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/26702.png?v=0)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.